Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Alnylam Pharmace. buy HC Wainwright

Start price
€189.54
03.03.23 / 50%
Target price
€390.56
03.03.24
Performance (%)
-25.40%
End price
€141.40
04.03.24
Summary
This prediction ended on 04.03.24 with a price of €141.40. The prediction for Alnylam Pharmace. disappointed with a performance of -25.40%. HC_Wainwright has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. HC_Wainwright has 50% into this prediction

Alnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.

Performance without dividends (%)
Name 1w 1m 1y
Alnylam Pharmace. 5.228% 5.228% -25.629%
iShares Core DAX® 3.178% 0.980% 15.331%
iShares Nasdaq 100 2.972% 0.925% 39.831%
iShares Nikkei 225® 0.545% -4.556% 17.661%
iShares S&P 500 2.367% 0.833% 30.000%

Comments by HC_Wainwright for this prediction

In the thread Alnylam Pharmace. diskutieren
Prediction Buy
Perf. (%) -25.40%
Target price 390.557
Change
Ends at 03.03.24

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $415.00 price target on the stock.
Ratings data for ALNY provided by MarketBeat

In the thread Trading Alnylam Pharmace.
Prediction Buy
Perf. (%) -25.40%
Target price 390.557
Change
Ends at 03.03.24

Die von HC_Wainwright gewählte maximale Laufzeit wurde überschritten

Current prediction by HC_Wainwright for Alnylam Pharmace.

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€166.80
07.08.23
€368.23
07.08.24
-14.93%
08.05.24

Stopped prediction by HC_Wainwright for Alnylam Pharmace.

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€140.20
07.05.24
€371.08
07.05.25
1.21%
08.05.24

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€138.00
05.03.24
€363.68
05.03.25
2.83%
08.05.24

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€170.20
15.12.23
€362.53
15.12.24
-16.63%
08.05.24

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€160.40
15.11.23
€363.52
15.11.24
-11.53%
08.05.24

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€158.40
11.10.23
€372.05
11.10.24
-11.93%
08.05.24

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€168.00
18.09.23
€378.55
18.09.24
-15.54%
08.05.24